US Patent Issued to ConverGene, The United States of America, as Represented by the Secretary, Department of Health and Human Services on Dec. 16 for "Small molecule bromodomain inhibitors and uses therof" (Maryland, Virginia, Pennsylvania Inventors)

ALEXANDRIA, Va., Dec. 16 -- United States Patent no. 12,497,395, issued on Dec. 16, was assigned to ConverGene LLC and The United States of America, as Represented by the Secretary, Department of Health and Human Services.

"Small molecule bromodomain inhibitors and uses therof" was invented by Jeffrey W. Strovel (Laurel, Md.), Makoto Yoshioka (Gaithersburg, Md.), David J. Maloney (Point of Rocks, Md.), Shyh Ming Yang (Doylestown, Pa.), Ajit Jadhav (Chantilly, Va.) and Daniel Jason Urban (Poolesville, Md.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to compounds that bind to and otherwise modulate the activity of bromodomain-containing proteins, including BRD4, to processes for...